Simbolo | YTM % | Volume | Prezzo % | Cedola % | Data di maturazione | Importo in eccesso | Valore nominale | Importo min. denominazione | Emittente |
---|---|---|---|---|---|---|---|---|---|
6,92% | 195 K | 65,48% | 3,18% | 2050-07-09 | 2 B USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
6,78% | 430 K | 64,54% | 3,38% | 2060-07-09 | 1 B USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
6,47% | 15 K | 73,44% | 3,03% | 2040-07-09 | 1,5 B USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
TTKPH4369980Baxalta Incorporated 5.25% 23-JUN-2045 | 6,08% | 4 K | 92,46% | 5,25% | 2045-06-23 | 500,41 M USD | 1.000,00 USD | 2.000,00 USD | Baxalta, Inc. |
5,99% | 10,6 M | 97,73% | 5,80% | 2064-07-05 | 500 M USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
5,87% | 2,71 M | 97,57% | 5,65% | 2054-07-05 | 600 M USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
5,73% | 2,08 M | 99,28% | 5,65% | 2044-07-05 | 800 M USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
5,31% | 4,04 M | 99,92% | 5,30% | 2034-07-05 | 1,1 B USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
5,28% | 2,22 M | 86,99% | 2,05% | 2030-03-31 | 2,5 B USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
4,84% | 5,07 M | 100,51% | 5,00% | 2028-11-26 | 1,73 B USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
TTKPH4370840Baxalta Incorporated 4.0% 23-JUN-2025 | 4,78% | 3,94 M | 99,74% | 4,00% | 2025-06-23 | 800,17 M USD | 1.000,00 USD | 2.000,00 USD | Baxalta, Inc. |
UUS82481LAD1SHIRE ACQUIST.I.IE 16/26 | 4,74% | 0 | 97,72% | 3,20% | 2026-09-23 | 1,5 B USD | 1.000,00 USD | 2.000,00 USD | Shire Acquisitions Investments Ireland DAC |
4,27% | 0 | 78,89% | 2,00% | 2040-07-09 | 1 B EUR | 1.000,00 EUR | 100.000,00 EUR | Takeda Pharmaceutical Co., Ltd. | |
3,45% | 0 | 87,78% | 1,38% | 2032-07-09 | 1 B EUR | 1.000,00 EUR | 100.000,00 EUR | Takeda Pharmaceutical Co., Ltd. | |
3,16% | 0 | 99,22% | 3,00% | 2030-11-21 | 1,5 B EUR | 1.000,00 EUR | 100.000,00 EUR | Takeda Pharmaceutical Co., Ltd. | |
3,06% | 0 | 92,03% | 1,00% | 2029-07-09 | 850 M EUR | 1.000,00 EUR | 100.000,00 EUR | Takeda Pharmaceutical Co., Ltd. | |
2,87% | 0 | 95,26% | 0,75% | 2027-07-09 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | Takeda Pharmaceutical Co., Ltd. | |
2,78% | 0 | 99,11% | 2,25% | 2026-11-21 | 1,5 B EUR | 1.000,00 EUR | 100.000,00 EUR | Takeda Pharmaceutical Co., Ltd. | |
2,71% | 0 | 116,57% | 5,00% | 2028-11-26 | 22,68 M USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
SSHPG4260178Baxalta Incorporated 4.0% 23-JUN-2025 | — | — | — | 4,00% | 2025-06-23 | 303 K USD | 1.000,00 USD | 2.000,00 USD | Baxalta, Inc. |
— | — | — | 5,00% | 2028-11-26 | 22,68 M USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |